About the Event

The MTPConnect WA Life Sciences Innovation Hub invites you to join the monthly WA MTP Sector Spotlight Series event.

Our monthly breakfast series is an opportunity for representatives from across the MTP sector to connect, collaborate and learn about upcoming opportunities, and hear the stories and successes of WA organisations developing health and medical innovations. Join us over a light breakfast in the last week of each month at the Harry Perkins Institute of Medical Research.

Featuring NeuroScientific Biopharmaceuticals Ltd – transforming how we approach the understanding and treatment of neurodegenerative disease.

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) is an Australian drug development company developing novel peptide-based pharmaceutical products that target a number of neurological degenerative conditions with high unmet medical need, such as Alzheimer’s disease, Multiple Sclerosis and diseases of the optic nerve.

About our speaker: Dr Alexandra Heaton – Director of Operations, NeuroScientific Biopharmaceuticals Ltd (NSB)

Dr Heaton holds a PhD in Neuroscience from the University of Western Australia with her research concentrated on enhancing neuroplasticity and cognition in children.

Alexandra's role at NSB covers operational logistics, product manufacturing, investor relations and corporate development.

Prior to joining NSB, Alexandra led US Business Development at Linear Clinical Research focusing on attracting partnerships with US biotechnology and pharmaceutical companies and coordinating early phase trials start-ups. She also has experience as a biotech co-founder.

Dr Heaton will discuss the company’s vision to improve the understanding and treatment of neurodegenerative disease, future opportunities for the biopharmaceuticals industry in WA, and take questions from the audience.

---